DRD Biotech
We creating rapid diagnostics in Russia
Development and manufacturing of diagnostic devices for laboratories and point-of-care
Products
Laboratory and rapid diagnostic tests
NR2 antibodies
Biomarker of cerebral ischemia.
A high blood concentration of antibodies to NR2 (above the threshold of 2.0 ng / ml) correlates with an increased risk of ischemic stroke. The results of several studies have shown that an increase in the level of antibodies to NR2 above thresholds is a predictor of the development of transient ischemic attacks and / or ischemic stroke.
A high blood concentration of antibodies to NR2 (above the threshold of 2.0 ng / ml) correlates with an increased risk of ischemic stroke. The results of several studies have shown that an increase in the level of antibodies to NR2 above thresholds is a predictor of the development of transient ischemic attacks and / or ischemic stroke.
Rapid test for the brain damage
We are developing rapid tests for the diagnosis of Ischemic Stroke and Traumatic Brain Injury based on key biomarkers of brain damage.
More details
Our partners
Our partners are research centers and medical companies from Russia, the USA and Europe.
Contacts
+7 495 105 99 16
office@drdbiotech.ru
Bolshoy Bulvar, 42 block 1, office 367, Moscow, Russia
office@drdbiotech.ru
Bolshoy Bulvar, 42 block 1, office 367, Moscow, Russia
Contact us
Just enter your contact details.